Who owns Cymabay Therapeutics?
- CUSIP Number: 23257d103
Tip: Access positions for across all investors
Analyze quarterly positions in Cymabay Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Cymabay Therapeutics stock
Who bought or sold Cymabay Therapeutics this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
venBio Select Advisor | 11M | $262M | 8% | Dec 2023 |
|
Nicholas Investments Partners | 435k | $10M | -76% | Dec 2023 |
|
Alliancebernstein | 350k | $8.3M | 246% | Dec 2023 |
|
Wellington Management Company | 203k | $4.8M | 100% | Dec 2023 |
|
Algert Coldiron Investors | 85k | $2.0M | -9% | Dec 2023 |
|
ALPS Advisors | 75k | $1.8M | 4% | Dec 2023 |
|
MetLife Investment Advisors | 59k | $1.4M | 15% | Dec 2023 |
|
American International | 56k | $1.3M | 15% | Dec 2023 |
|
Golden State Equity Partners | 54k | $1.3M | 9% | Dec 2023 |
|
Healthcare Of Ontario Pension Plan Trust Fund | 45k | $1.1M | 100% | Dec 2023 |
|
Metropolitan Life Insurance Company | 6.4k | $152k | 14% | Dec 2023 |
|
Tucker Asset Management | 3.7k | $89k | 100% | Dec 2023 |
|
EverSource Wealth Advisors | 786.00 | $19k | 0% | Mar 2024 |
|
IFP Advisors | 650.00 | $15k | 0% | Dec 2023 |
|
Able Wealth Management | 83.00 | $2.0k | 100% | Dec 2023 |
|
Federated Investors | 3.00 | $71.000100 | 100% | Dec 2023 |
|
Activest Wealth Management | 0 | $0 | -100% | Mar 2024 |
|